← Back to Search

Telemedicine Interventions for Glaucoma (SIGHT Trial)

N/A

Recruiting

Led By Paula Anne Newman-Casey, MD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

> or = to 18 years of age

Must not have

Cognitive impairment

Significant eye pain

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if educational and counseling interventions can help patients keep their follow-up appointments with their physicians.

Who is the study for?

This trial is for adults over 18 with glaucoma. It's not suitable for those experiencing sudden vision changes, significant eye pain, pregnant women, prisoners, or individuals with cognitive impairments.

What is being tested?

The study is testing whether personalized eHealth education and motivational interviews can help patients stick to their follow-up appointments with doctors. This research involves multiple sites and randomly assigns participants to different groups.

What are the potential side effects?

Since the interventions involve educational materials and counseling sessions rather than medications or medical procedures, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have difficulty with memory or thinking clearly.

Select...

I am experiencing severe eye pain.

Select...

I have experienced sudden changes in my vision.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Physician Follow up

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Personalized eHealth Education & Motivational InterviewingExperimental Treatment1 Intervention

Personalized eHealth Glaucoma Education \& Motivational Interviewing

Group II: Standard EducationActive Control1 Intervention

Participant will receive standard glaucoma education.

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,852 Previous Clinical Trials

6,432,342 Total Patients Enrolled

7 Trials studying Glaucoma

1,102 Patients Enrolled for Glaucoma

Centers for Disease Control and PreventionFED

887 Previous Clinical Trials

21,996,193 Total Patients Enrolled

5 Trials studying Glaucoma

5,194 Patients Enrolled for Glaucoma

Paula Anne Newman-Casey, MD1.01 ReviewsPrincipal Investigator - University of Michigan

University of Michigan

1Patient Review

The staff member in question was unprofessional, to say the least. It reflects poorly on Paula that she would allow someone like that to represent her.